Peer support for TB and HIV treatment in Uganda
Part of Immune system & allergy, Infections clinical trials.
This trial tests a peer-led education and counseling program to help people with TB and HIV stick with their treatment. It may help improve understanding, motivation, and day-to-day adherence to medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your TB doctor or clinic lists you as a new patient, or someone with relapse, treatment failure, or previously missed follow-up
- You have a TB diagnosis recorded in the clinic’s TB treatment register
- You can be screened and invited within 30 days of starting TB treatment
- You do not have possible or confirmed drug-resistant TB
- You live within 40 km of the enrolling clinic and can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This study tests ways to help young people in Uganda prevent HIV or stay healthy if they already have HIV. It offers free prevention pills or injections and care for those living with HIV.
This trial tests whether adding dedicated nursing support in and out of the hospital helps people with tuberculosis complete their treatment and recover better.
This study tests a community-friendly way to deliver TB prevention medicine (called TPT) to people's homes in Kenya. Researchers want to see if bringing screening and treatment to your house—instead of making you go to a clinic—helps more people start and finish TB prevention, which can reduce TB spread in your community.
This trial helps young people aged 18 to 24 living with HIV in three districts of Zambia. It aims to reduce stigma and build job skills to improve their lives.
This trial tests a new “triple-dose” set of medicines to treat people whose tuberculosis (TB) has come back in the lungs. If you qualify, the goal is to improve cure rates and reduce the chance of TB returning again.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.